LITH - BioELife Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
0.9500
-0.1500 (-13.64%)
As of 1:20PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close1.1000
Open1.1500
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.9000 - 1.1600
52 Week Range0.1820 - 1.7400
Volume316,828
Avg. Volume166,685
Market Cap8.939M
Beta (5Y Monthly)1.04
PE Ratio (TTM)N/A
EPS (TTM)-0.1710
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • BioELife Corp Adds Michael Terpin to Advisory Board as Marketing & Public Relations Industry Expert
    GlobeNewswire

    BioELife Corp Adds Michael Terpin to Advisory Board as Marketing & Public Relations Industry Expert

    BioELife Corp. (OTC QB: LITH) (the “Company”) is pleased to announce that Michael Terpin is joining its Advisory Board of external experts to assist the Company in its strategic development. Mr. Michael Terpin brings over 35 years of marketing, public relations, and management experience to help assist BioELife in its communication and social media efforts. Michael Terpin is founder and CEO of Transform Group, whose divisions include Transform PR, a global public relations firm that has served more than 200 clients in the blockchain and high technology fields including Augur, Bancor, Bittrex, Ethereum, Factom, Golem, Kraken, Lisk, Neo, SALT Lending, VideoCoin, and WAX; Transform Events, which includes CoinAgenda, the oldest high-end conference series for investors and blockchain innovators since 2014 (including the first blockchain conferences in the Caribbean), and Transform Strategies, the company’s advisory division.

  • BioELife Corp Adds Pharmaceutical Industry Veteran to Advisory Board for Manufacturing & Distribution of Products to Help Defend Against Viral (COVID-19) and Bacterial Contamination
    GlobeNewswire

    BioELife Corp Adds Pharmaceutical Industry Veteran to Advisory Board for Manufacturing & Distribution of Products to Help Defend Against Viral (COVID-19) and Bacterial Contamination

    BioELife Corp. (OTC QB: LITH) (the “Company”) is pleased to announce that William (Bill) Marciniak is joining its Advisory Board of external experts to assist the Company in its strategic development. Mr. Marciniak brings over 35 years of pharmaceutical and manufacturing experience to help BioELife expand its product line, manufacturing and distributor relationships. As a co-founder of RxElite, Mr. Marciniak achieved great success developing and producing albuterol and ipratropium.

  • BioELife Corp. Establishes Advisory Board for Research and Development of Products to Help Defend Against Virus (COVID-19) and Bacteria Contamination
    GlobeNewswire

    BioELife Corp. Establishes Advisory Board for Research and Development of Products to Help Defend Against Virus (COVID-19) and Bacteria Contamination

    BioELife Corp. (OTC QB: LITH) (the “Company”), is pleased to announce that it is forming an Advisory Board of external experts from various specialties to assist the Company in its strategic development. As part of this initiative, the Company is also pleased to announce that a leading chemist, Susan Raffy, will join the new Advisory Board. Ms. Raffy was instrumental in the development of the Company’s BioEDefense Hand Sanitizer, which exceeds the CDC requirements for ethyl alcohol, and is fortified with 50 mg per ounce of CBD.

  • BioELife Corp Expands Coronavirus (COVID-19) Prevention Product Line and Receives Purchase Order from New Distributor
    GlobeNewswire

    BioELife Corp Expands Coronavirus (COVID-19) Prevention Product Line and Receives Purchase Order from New Distributor

    BioELife Corp. (OTC QB: LITH) (the “Company”), is pleased to announce that it continues to achieve several key objectives for Q1 2020. The Company received a purchase order from a new distributor for the next production run of its entire product line including back-ordered BioEDefense products recently launched to help the world-wide crisis surrounding the Coronavirus (COVID-19). The Company has added the RespiPro Virus Killer nanofiber mask to its ecommerce site while ordering additional inventory for the BioEDefense line of products with expected delivery in April.

  • BioELife Corp Mobilizes to Produce and Distribute Coronavirus (COVID-19) and Bacteria Protection Products
    GlobeNewswire

    BioELife Corp Mobilizes to Produce and Distribute Coronavirus (COVID-19) and Bacteria Protection Products

    BioELife Corp. (OTC QB: LITH) (the “Company”), formerly known as US Lithium Corp., announces that the Company’s chemists and medical advisors have completed their specifications for, and selection of, virus and bacteria protection products including a powerful hand sanitizer fortified with CBD and ultra-protective Nano-Fiber Face Masks. The core of the masks consists of the latest technology using four layers of protection including a nanofiber membrane, RespiPro, with a 60 nano-meter opening that mechanically captures 99.9% of viruses and bacteria.

  • BioELife Corp. (US Lithium Corp.) Enters Into Significant Product Purchase Agreement, Launches Corporate Website and Completes Name Change
    GlobeNewswire

    BioELife Corp. (US Lithium Corp.) Enters Into Significant Product Purchase Agreement, Launches Corporate Website and Completes Name Change

    BioELife Corp. (OTC QB: LITH) (the “Company”), formerly known as US Lithium Corp., is pleased to announce that it has achieved several key milestones during its initial month of operating its CBD business. The Company received a purchase order for its entire first production run of ChiroRub 2000, its proprietary relief rub formulation containing 1,000 mg of CBD per ounce. It is also extending packaging options across several product lines.

  • US Lithium Corp (BioELife) Launches ECommerce Website For Wholesale Customers And Consumers
    GlobeNewswire

    US Lithium Corp (BioELife) Launches ECommerce Website For Wholesale Customers And Consumers

    US Lithium Corp (OTC QB: LITH) (the “Company”), soon to be renamed BioELife, is pleased to announce that its CBD business has launched its beta ecommerce website, www.bioelife.net. This includes adult CBD gum drops, the Company’s highly concentrated topical 2,000 mg CBD intensive pain cream, premium pre-rolls and flower from its farm partner Hemp Heaven Farms. “BioELife.net offers wholesalers a convenient method to view our expanding product line and order products for distribution,” stated Gregory Rotelli, Chairman of the Board and President of LITH.

  • US Lithium Corp. (BioELife Corp.) Releases ChiroRub 2000, the Next Generation CBD Pain Cream
    GlobeNewswire

    US Lithium Corp. (BioELife Corp.) Releases ChiroRub 2000, the Next Generation CBD Pain Cream

    US Lithium Corp (OTC QB: LITH) (the “Company”), soon to be renamed BioELife Corp., is pleased to announce that it has completed production and began shipping its latest pain cream, ChiroRub 2000. The proprietary formulation, containing 2,000 mg of CBD, has been doctor and patient tested and is one of the most effective pain relief creams currently available on the market today. ChiroRub 2000 was developed in conjunction with leading physicians, chiropractors, and medical professionals who evaluated and validated the product’s efficacy throughout several developmental phases.

  • US Lithium Corp. Announces It Has Approved Name Change To BioELife Corp. To Reflect New Direction
    GlobeNewswire

    US Lithium Corp. Announces It Has Approved Name Change To BioELife Corp. To Reflect New Direction

    US Lithium Corp (OTC QB: LITH) (the ”Company”) is pleased to announce that its Board of Directors and shareholders have approved an amendment to the Articles of Incorporation changing the name of the corporation from U.S. Lithium Corp. to BioELife Corp. The name change will better reflect the Company’s new strategic focus on the rapidly growing CBD market. The Company expects this action will become effective within the next 30 days. The Company will also be launching a new website and seek a new trading symbol for its common stock immediately after the name change becomes effective.

  • US Lithium Corp. Wins Manufacturing & Distribution Contract From International Healthcare Network
    GlobeNewswire

    US Lithium Corp. Wins Manufacturing & Distribution Contract From International Healthcare Network

    US Lithium Corp (OTC QB: LITH) (the ”Company”) is pleased to announce that its CBD manufacturing business has been awarded an exclusive purchase and distribution agreement by International Healthcare Network (“IHN”) for at least four of its products. This multiyear agreement is an example of the Company’s focus on securing large distributor arrangements with proven sales and medical organizations.

  • US Lithium Corp. Enters CBD Industry Through Strategic Asset Acquisition
    GlobeNewswire

    US Lithium Corp. Enters CBD Industry Through Strategic Asset Acquisition

    US Lithium Corp. (OTC QB: LITH) (the ”Company”) is pleased to announce that, effective January 20, 2020, it has acquired four cannabinoid related contracts between Hemp Cloud 9 and four unrelated parties in exchange for 4.7M shares of LITH stock. As a result of these acquisitions the Company will change its primary business from minerals to cannabinoids. The Company also intends to change its name, stock symbol and website within the next 30 days to better reflect this new strategic direction.

  • US Lithium Corp. Provides Update and Additional Background on its Strategic Review of the CBD Market
    GlobeNewswire

    US Lithium Corp. Provides Update and Additional Background on its Strategic Review of the CBD Market

    US Lithium Corp’s (OTC QB: LITH) recently announced strategic review and evaluation of future prospects and opportunities continues with several potential acquisition candidates identified. “Our Board is committed to maximize shareholder value and, in this light, we have identified accretive acquisition opportunities that would potentially position our company in a high growth industry while also helping improve the lives of individuals,” stated Gregory Rotelli, Chairman of the Board.

  • US Lithium Corp. Evaluating Acquisitions in CBD Market
    GlobeNewswire

    US Lithium Corp. Evaluating Acquisitions in CBD Market

    US Lithium Corp. (OTC QB: LITH) and its Board of Directors announce that it is conducting a strategic review of the Company in order to identify future prospects and opportunities that could deliver exceptional growth and increase shareholder value. “Our Board continues to be committed to evaluating all options that maximize shareholder value,” said Gregory Rotelli, Chairman of the Board. According to the Brightfield Group, CBD sales in the US are projected to grow from around $600 million in 2018 to $23.7 Billion by 2023, a CAGR in excess of 100%.